Circassia Pharmaceuticals Plc Holding(s) in Company (5122C)
14 April 2017 - 3:02AM
UK Regulatory
TIDMCIR TIDMAV.
RNS Number : 5122C
Circassia Pharmaceuticals Plc
13 April 2017
For filings with the FCA
include the annex
For filings with issuer exclude
the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
-------------------------------------------------------------------------------------------------------
1. Identity of the issuer or Circassia Pharmaceuticals
the underlying issuer Plc
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------------- ------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
-------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
-----------------------------------------------------------------------------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
-----------------------------------------------------------------------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
-----------------------------------------------------------------------------------------------------
An event changing the breakdown of voting rights
-----------------------------------------------------------------------------------------------------
Other (please CHANGE TO THE NUMBER OF SHARES IN
specify): ISSUE
----------------------------------------------------------- ----------------------------------------
3. Full name of person(s) Aviva plc & its subsidiaries
subject to the
notification obligation:
(iii)
------------------------------------------------------------- ----------------------------------------
4. Full name of shareholder(s) Registered Holder:
(if different from 3.):(iv)
Chase (GA Group) Nominees
Limited 13,534,518*
HSBC Global Custody Nominee
(UK) Limited 50,256*
State Street Nominees Limited
202,422*
* denotes direct interest
Chase Nominees Limited 452,588
Vidacos Nominees Limited 272,030
------------------------------------------------------------- ----------------------------------------
5. Date of the transaction 12 April 2017
and date on
which the threshold is
crossed or
reached: (v)
------------------------------------------------------------- ----------------------------------------
6. Date on which issuer 13 April 2017
notified:
------------------------------------------------------------- ----------------------------------------
7. Threshold(s) that is/are 5% to <5% Change at Combined
crossed or Interest Level
reached: (vi, vii) and 5% to 4% Direct (Box 8A
& 8B)
------------------------------------------------------------- ----------------------------------------
8. Notified details:
--------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
--------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
----------------- ------------------------------ -----------------------------------------------------------
Number Number Number Number of voting % of voting
of of of shares rights rights (x)
Shares Voting
Rights
----------------- ---------------- ------------ ------------- ----------------------- -------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
----------------- ---------------- ------------ ------------- ----------- ---------- ------- ----------
Ordinary
Shares
GB00BJVD3B28 16,516,463* 16,516,463* 14,511,814 13,787,196 724,618 4.15% 0.22%
---------------- ------------ ------------- ----------- ---------- ------- ----------
* Includes right to recall loaned shares (2,074,649)
--------------------------------------------------------------------------------------------------------------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
----------------- ---------------- --------------------------- ----------------------- -------------------
2,004,649*
RIGHT TO RECALL
LOANED SHARES N/A N/A *Direct interest 0.60%
----------------- ---------------- --------------------------- ----------------------- -------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
-----------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights (xix,
(xvii) period refers to xx)
(xviii)
------------------ --------- ----------- ------------ ------------------- ----------------
Nominal Delta
------------------ --------- ----------- ------------ ------------------- -------- ------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
16,516,463 4.97%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
-----------------------------------------------------------------
The voting rights are managed and controlled by Aviva
Investors Global Services Limited, with the following
chain of controlled undertakings:-
Aviva Investors Global Services Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Investors Holdings Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Aviva Investors Global Services Limited (wholly owned
subsidiary of Aviva Investors Holdings Limited)
-----------------------------------------------------------------
Proxy Voting:
-------------------------------------------------------------------------
10. Name of the proxy holder: See Section 4
------------------------------------- ----------------------------------
11. Number of voting rights proxy
holder will cease
to hold:
------------------------------------- ----------------------------------
12. Date on which proxy holder will
cease to hold
voting rights:
------------------------------------- ----------------------------------
13. Additional information: Figures are based on a total
number of voting rights of
332,244,588 as per the Company's
Total Voting Rights Update
Announcement of 12 April
2017.
------------------------------------- ----------------------------------
14. Contact name: Julien Cotta
------------------------------------- ----------------------------------
15. Contact telephone number: 01865 405560
------------------------------------- ----------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUOVNRBWASAAR
(END) Dow Jones Newswires
April 13, 2017 13:02 ET (17:02 GMT)
Circassia (LSE:CIR)
Historical Stock Chart
From Apr 2024 to May 2024
Circassia (LSE:CIR)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Circassia Group Plc (London Stock Exchange): 0 recent articles
More Circassia Pharmaceuticals News Articles